Emeis Stock Falls 2.5% and Drops Below Its MM50, Among the Worst in the SBF 120
The health services group's stock significantly declines in early afternoon trading, in a downward trending Parisian market. The stock is among the biggest losers in its reference index, even though it was trading above its short moving averages at the beginning of last week.
The Stock Falls Below the MM50 and Approaches the Support at €13.64
Emeis stock loses 2.41% to €14.15 after a last close at €14.50. The decline erases part of the rebound initiated last week, when the stock moved back above a closely watched technical threshold. The price falls below the MM50 (€14.41), with a gap of 1.80% against the stock, while remaining slightly above the MM20 at €14.06. The RSI at 55 remains neutral, indicating neither overbought nor oversold conditions. The scenario of a new test of the support at €13.64, already tested on June 24, becomes relevant again if the selling pressure continues during the session.
The immediate resistance is identified at €15.11. The stock ranks among the largest declines in the SBF 120, which is down 0.14%. The decline is part of a tumultuous sequence since the beginning of the month, marked by a series of rebounds and tests of the support at €13.64. Over a month, Emeis loses 6.35%, while the performance over three months is still positive at 14.21% and that over one year at 33.49%.
A Decline in a Parisian Market Weighed Down by Caution on Cyclical Stocks
The CAC 40 loses 0.19% at 8,369 points during the session and the SBF 120 is down 0.14%, in an international context marked by the announced pause between Washington and Tehran on the Ormuz file and by Ukrainian strikes on Russian energy infrastructures. The VIX relaxes to 18.32 points (-3.02%), a sign of a risk aversion that is not worsening overall, even though several Parisian cyclical stocks (Air France-KLM, Vinci, EssilorLuxottica) are alongside Emeis at the bottom of the ranking. The stock's trajectory since autumn 2025 remains supported by the half-yearly results published in early October, which had triggered several sessions of marked increase.
The movement of the day is part of a consolidation phase after the bullish course achieved over the last three months. The next technical milestones to watch remain the support at €13.64 on the downside and the MM50 at €14.41 on the rebound.
